Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
Moodys
McKinsey
AstraZeneca

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SPIRIVA

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Spiriva

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00144196 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) Completed Boehringer Ingelheim Phase 4 2004-03-01 To show that treatment with tiotropium inhalation capsules (18 μg q.d.) via HandiHaler® improves lung function in patients with mild COPD according to Swedish guidelines.
NCT00144326 A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (CO Completed Boehringer Ingelheim Phase 3 2003-07-01 The objective of this study is to determine if tiotropium (Spiriva, Bromuro de Tiotropio) 18 mcg once daily by oral inhalation compared to placebo increases the magnitude of daily physical activity observed in COPD patients, measured using an accelerometer.
NCT00144339 Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients Completed Boehringer Ingelheim Phase 3 2002-12-01 The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung function over time in patients with COPD.
NCT00157235 Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients Completed Boehringer Ingelheim Phase 3 2002-09-01 The objective of this trial is to determine whether tiotropium inhalation capsules (Spiriva, Bromuro de Tiotropio), compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Spiriva

Condition Name

Condition Name for Spiriva
Intervention Trials
Pulmonary Disease, Chronic Obstructive 41
Chronic Obstructive Pulmonary Disease 18
COPD 13
Asthma 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Spiriva
Intervention Trials
Pulmonary Disease, Chronic Obstructive 70
Lung Diseases 69
Chronic Disease 41
Lung Diseases, Obstructive 39
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Spiriva

Trials by Country

Trials by Country for Spiriva
Location Trials
United States 486
Canada 62
Germany 32
Australia 30
China 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Spiriva
Location Trials
South Carolina 26
California 24
Florida 24
North Carolina 23
Ohio 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Spiriva

Clinical Trial Phase

Clinical Trial Phase for Spiriva
Clinical Trial Phase Trials
Phase 4 33
Phase 3 26
Phase 2/Phase 3 2
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Spiriva
Clinical Trial Phase Trials
Completed 72
Recruiting 8
Terminated 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Spiriva

Sponsor Name

Sponsor Name for Spiriva
Sponsor Trials
Boehringer Ingelheim 47
Pearl Therapeutics, Inc. 9
Pfizer 6
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Spiriva
Sponsor Trials
Industry 93
Other 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Johnson and Johnson
Mallinckrodt
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.